Cloitre A, Duval X, Tubiana S, Giraud P, Veyrac G, Nosbaum A, Gouraud A, Mahé J, Lesclous P. Antibiotic prophylaxis for the prevention of infective endocarditis for dental procedures is not associated with fatal adverse drug reactions in France. Med Oral Patol Oral Cir Bucal. 2019 May 1;24 (3):e296-304.   

 

doi:10.4317/medoral.22818

http://dx.doi.org/doi:10.4317/medoral.22818

-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

1. Jones T, Baumgartner L, Bellows M, Breese B, Kuttner A, McCarty M, et al. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections - Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis. Circulation. 1955;11:317-320.

 

2. National Institute for health and Care Excellence. Guideline 064 - Prophylaxis against infective endocarditis. NICE 2015. https://www.nice.org.uk/guidance/cg64. [Accessed on January18, 2018].

 

3. Thornhill MH, Dayer MJ, Lockhart PB Mc Gurk M, Shanson D, Prendergast B, Chambers JB. A change in the NICE guidelines on antibiotic prophylaxis. Br Dent J. 2016;221:112-4.
https://doi.org/10.1038/sj.bdj.2016.554
https://doi.org/10.1038/sj.bdj.2016.470

 

4. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: Guidelines from the American Heart Association. Circulation. 2007;116:1736-54.
https://doi.org/10.1161/CIRCULATIONAHA.106.183095
PMid:17446442

 

5. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:3075-123.
https://doi.org/10.1093/eurheartj/ehv319

 

6. Agence Nationale de Sécurité du Médicament et des produits de santé. Prescription des antibiotiques en pratique bucco-dentaire. [Antibiotic prescription in dental and oral surgery: guidelines] ANSM 2011. http://ansm.sante.fr/Mediatheque/Publications/Recommandations-Medicaments. [Accessed on February 16, 2018].

 

7. Lockhart PB, Blizzard J, Maslow AL, Brennan MT, Sasser H, Carew J. Drug cost implications for antibiotic prophylaxis for dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:345-53.
https://doi.org/10.1016/j.oooo.2012.10.008
PMid:23265984

 

8. Lee P, Shanson D. Results of a UK survey of fatal anaphylaxis after oral amoxicillin. J Antimicrob Chemother. 2007;60:1172-3.
https://doi.org/10.1093/jac/dkm315
PMid:17761735

 

9. Thornhill MH, Dayer MJ, Prendergast B, Baddour LM, Jones S, Lockhart PB. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother. 2015;70:2382-8.
https://doi.org/10.1093/jac/dkv115
PMid:25925595 PMCid:PMC4580535

 

10. Bombassaro AM, Wetmore SJ, John MA. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures. J Can Dent Assoc. 2001;67:20-2.

 

11. Tubiana S, Blotière PO, Hoen B, Lesclous P, Millot S, Rudant J, et al. Dental procedures, antibiotic prophylaxis, and endocarditis among people with prosthetic heart valves: nationwide population based cohort and a case crossover study. BMJ. 2017;58:j3776.
https://doi.org/10.1136/bmj.j3776

 

12. Moore M, Noblet C, Kreft-Jais C, Lagier G, Ollagnier M, Imbs JL. French pharmacovigilance database system: examples of utilisation. Therapie. 1995;50:557-62.

 

13. Begaud B, Evreux JC, Jouglard J, Lagier G. Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France. Therapie. 1985;40:111-8.

 

14. Mozzicato P. Standardised MedDRA Queries. Drug Saf. 2007;30:617-9.
https://doi.org/10.2165/00002018-200730070-00009
PMid:17604415

 

15. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A. Second symposium on the definition and management of anaphylaxis. J Allergy Clin Immunol. 2006;117:391-7.
https://doi.org/10.1016/j.jaci.2005.12.1303
PMid:16461139

 

16. Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977;8009:466-9.
https://doi.org/10.1016/S0140-6736(77)91953-5

 

17. Duval X, Alla F, Hoen B, Danielou F, Darrieu S, Delahaye F, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or witout antibiotic prophylaxis. Clin Infect Dis. 2006;42:e102-7.
https://doi.org/10.1086/504385

 

18. Bor DH, Himmelstein DU. Endocarditis prophylaxis for patients with mitral valve prolapse. A quantitative analysis. Am J Med. 1984;76:711-7.
https://doi.org/10.1016/0002-9343(84)90300-0

 

19. Devereux RB, Frary CJ, Kramer-Fox R, Roberts RB, Ruchlin HS. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol. 1994;74:1024-9.
https://doi.org/10.1016/0002-9149(94)90853-2

 

20. Clemens JD, Ransohoff DF. A quantitative assessment of pre-dental antibiotic prophylaxis for patients with mitral valve prolapse. J Chronic Dis. 1984;37:531-44.
https://doi.org/10.1016/0021-9681(84)90004-3

 

21. Tzukert AA, Leviner E, Benoliel R, Katz J. Analysis of the American Heart Association for the prevention of infective endocarditis. Oral Surg, Oral Med, Oral Pathol. 1986;62:276-9.
https://doi.org/10.1016/0030-4220(86)90008-3

 

22. Seymour RA, Lowry R, Withworth JM, Martin MV. Infective endocarditis, dentistry and antibiotic prophylaxis; time for a rethink? Br Dent J. 2000;189:610-6.
https://doi.org/10.1038/sj.bdj.4800845a

 

23. Panesar SS, Javad S, de Silva D, Nwaru BI, Hickstein L, Muraro A, et al. The epidemiology of anaphylaxis in Europe: a systematic review. Allergy. 2013;68:1353-61.
https://doi.org/10.1111/all.12272
PMid:24117770

 

24. Ribeiro-Vaz I, Marques J, Demoly P, Polónia J, Rebelo Gomes E. Drug-induced anaphylaxis: a decade review of reporting to the Portuguese pharmacovigilance authority. Eur J Clin Pharmacol. 2013;69:673-81.
https://doi.org/10.1007/s00228-012-1376-5
PMid:22915040

 

25. Buffie CG, Jarchum I, Equinda M, Lipuma L, Gobourne A, Viale A, et al. Profound alterations of instestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect Immun. 2012;80:62-73.
https://doi.org/10.1128/IAI.05496-11
PMid:22006564 PMCid:PMC3255689

 

26. Lochmann O, Kohaut P, Vymola F. Anaphylactic shock following the administration of clindamycin. J Hyg Epidemiol Microbiol Immunol. 1997;21:441-7.

 

27. Muraro A, Roberts G, Worm M, Bilo MB, Brockow K, Fernandez-Rivas M, Santos AF, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69:1026-45.
https://doi.org/10.1111/all.12437
PMid:24909803

 

28. Renaudin JM, Beaudouin E, Ponvert C, Demoly P, Moneret-Vautrin DA. Severe drug-induced anaphylaxis: analysis of 333 cases recorded by the allergy vigilance network from 2002 to 2010. Allergy. 2013;68:929-37.
https://doi.org/10.1111/all.12168
PMid:23741979

 

29. Blanca M, Romano A, Torres MJ, Férnandez J, Mayorga C, Rodriguez J, et al. Update on the evaluation of hypersensivity reactions to betalactams. Allergy. 2009;64:183-93.
https://doi.org/10.1111/j.1398-9995.2008.01924.x
PMid:19133923

 

30. Torres MJ, Blanca M, Fernandez J, Romano A, de Weck A, Aberer W, et al. Diagnosis of immediate allergic reaction to beta-lactam antibiotics. Allergy. 2003;58:961-72.
https://doi.org/10.1034/j.1398-9995.2003.00280.x
PMid:14510712

 

31. Romano A, Blanca M, Torres MJ, Bircher A, Aberer W, Brockow K, et al. Diagnosis of nonimmediate allergic reaction to beta-lactam antibiotics. Allergy. 2004;59:1153-60.
https://doi.org/10.1111/j.1398-9995.2004.00678.x
PMid:15461594

 

32. Bégaud M, Martin K, Haramburu F, Moore N. Rates of spontaneous reporting of adverse drug reactions in France. JAMA. 2002;288:1588.
https://doi.org/10.1001/jama.288.13.1588
PMid:12350188

 

33. Backstrom M, Mjorndal T, Dahlqvist R. Under-reporting of serious adverse drug reactions in Sweden. Pharmacoepidemiol Drug Saf. 2004;13:483-7.
https://doi.org/10.1002/pds.962
PMid:15269932

 

34. Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29:385-96.
https://doi.org/10.2165/00002018-200629050-00003
PMid:16689555